{"version":"1.0","type":"link","title":"Nutritional Risk Index (NRI) predicts the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors (PD-1/PD-L1).","author_name":"Xu Y 외","author_url":"https://prs-insight.online/author/Xu%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/128639","thumbnail_width":1200,"thumbnail_height":630}